Sanctura XR

Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XRPerrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.
Holiday Drinks: Jazz Up Your Eggnog!
Becoming A Storm Trooper For Charity

Watch & Listen